Newbridge Financial Services Group’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,610
| Closed | -$4.6K | – | 1365 |
|
|
2023
Q3 | $4.6K | Sell |
3,610
-1,000
| -22% | -$1.28K | ﹤0.01% | 968 |
|
|
2023
Q2 | $1.5K | Sell |
4,610
-1,465
| -24% | -$478 | ﹤0.01% | 1172 |
|
|
2023
Q1 | $2.61K | Hold |
6,075
| – | – | ﹤0.01% | 1162 |
|
|
2022
Q4 | $3.22K | Hold |
6,075
| – | – | ﹤0.01% | 1144 |
|
|
2022
Q3 | $4K | Hold |
6,075
| – | – | ﹤0.01% | 1105 |
|
|
2022
Q2 | $7K | Hold |
6,075
| – | – | ﹤0.01% | 958 |
|
|
2022
Q1 | $12K | Hold |
6,075
| – | – | 0.01% | 901 |
|
|
2021
Q4 | $17K | Buy |
6,075
+5,965
| +5,423% | +$16.7K | 0.01% | 783 |
|
|
2021
Q3 | $1K | Hold |
110
| – | – | ﹤0.01% | 1357 |
|
|
2021
Q2 | $1K | Buy |
+110
| New | +$1K | ﹤0.01% | 1413 |
|